l-carnitine suppresses cisplatin-induced renal injury in rats: Impact on cytoskeleton proteins expression

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

We designed this work to examine the curative role of l-carnitine (LCAR) in a rat model of cisplatin (CDDP)-induced kidney injury. We induced kidney injury in rats by a single intraperitoneal injection of 5 mg/kg of CDDP. Fifteen days post injection, rats were orally supplemented with 354 mg/kg of LCAR for another 15 days. Kidney tissues were subjected to histo-biochemical analysis along with mRNA gene expression quantification for cytoskeleton proteins encoding genes (vimentin, nestin, and connexin 43) by real-time reverse transcription polymerase chain reaction. LCAR reversed CDDP-induced renal structural and functional impairments. LCAR significantly declined serum urea and creatinine concentrations, restored oxidant/antioxidant balance, reversed inflammation, and antagonized caspase 3-mediated apoptotic cell death in renal tissues. Moreover, LCAR effectively down-regulated cytoskeleton proteins mRNA levels, reflecting amelioration of CDDP-provoked podocyte injury. We concluded that LCAR has a favorable therapeutic utility against CDDP-induced kidney injury.

Cite

CITATION STYLE

APA

Ebrahim, O. F. A., Nafea, O. E., Samy, W., & Shawky, L. M. (2021). l-carnitine suppresses cisplatin-induced renal injury in rats: Impact on cytoskeleton proteins expression. Toxicology Research, 10(1), 51–59. https://doi.org/10.1093/toxres/tfaa092

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free